Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
GENE:
GNAS (GNAS Complex Locus)
i
Other names:
GNAS, GNAS Complex Locus, Guanine Nucleotide Binding Protein (G Protein), Alpha Stimulating Activity Polypeptide 1, Guanine Nucleotide-Binding Protein G(S) Subunit Alpha Isoforms XLas, Adenylate Cyclase-Stimulating G Alpha Protein, Alternative Gene Product Encoded By XL-Exon, Extra Large Alphas Protein, G Protein Subunit Alpha S, Secretogranin VI, Protein ALEX, NESP55, GNAS1, SCG6, GSP, Guanine Nucleotide-Binding Protein G(S) Subunit Alpha Isoforms Short, Guanine Nucleotide Regulatory Protein, Neuroendocrine Secretory Protein 55, Neuroendocrine Secretory Protein, Protein SCG6 (Secretogranin VI), Protein GNAS, C20orf45, GNASXL, PITA3
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
2778
Related tests:
‹
Guardant360® CDx (54)
MSK-IMPACT (21)
TruSeq®Amplicon - Cancer Panel (5)
Oncomine™ Pan-Cancer Cell-Free Assay (4)
Guardant360 TissueNext™ (2)
Archer® FusionPlex® Comprehensive Thyroid & Lung (CTL) Kit (1)
AVENIO ctDNA Expanded Kit
AnchorAIM® 72 gene detection for individualized treatment of solid tumors
Archer® FusionPlex® Myeloid Kit
Archer® VariantPlex® Comprehensive Thyroid and Lung (CTL) kit
Archer® VariantPlex® Myeloid panel
Archer® VariantPlex® Solid Tumor Kit
Archer™ VARIANTPlex™ Complete Solid Tumor panel
Find It®
Follow It®
FusionPlex™ Pan-Heme panel
InVisionSeq™
Liquid Trace™ Hematology
LiquidHALLMARK®
Myeloid Molecular Profile
NeoLAB® Solid Tumor Liquid Biopsy
Northstar Select™
OncoGuide™ NCC Oncopanel System
Oncomine Precision Assay
Oncomine™ Colon cfDNA Assay
OptiSeq™ Colorectal Cancer Panel
OptiSeq™ Lung Cancer Panel
OptiSeq™ Pan-Cancer Gene Panel
PancraGEN®
SOPHiA DDM™ Solid Tumor Plus Solution
SureSeq™ Pan-Myeloid Panel
Tempus xF Assay
ThyGeNEXT® + ThyraMIR®
TruSight Myeloid Sequencing Panel
TruSight Tumor 170 Assay
VarMap™ Pan-Cancer NGS Panel
oncoReveal™ Core LBx
oncoReveal™ Essential LBx
oncoReveal™ Multi-Cancer with CNV & RNA Fusion Panel
oncoReveal™ Solid Tumor v2 Panel
Guardant360® CDx (54)
MSK-IMPACT (21)
TruSeq®Amplicon - Cancer Panel (5)
Oncomine™ Pan-Cancer Cell-Free Assay (4)
Guardant360 TissueNext™ (2)
Archer® FusionPlex® Comprehensive Thyroid & Lung (CTL) Kit (1)
AVENIO ctDNA Expanded Kit
AnchorAIM® 72 gene detection for individualized treatment of solid tumors
Archer® FusionPlex® Myeloid Kit
Archer® VariantPlex® Comprehensive Thyroid and Lung (CTL) kit
Archer® VariantPlex® Myeloid panel
Archer® VariantPlex® Solid Tumor Kit
Archer™ VARIANTPlex™ Complete Solid Tumor panel
Find It®
Follow It®
FusionPlex™ Pan-Heme panel
InVisionSeq™
Liquid Trace™ Hematology
LiquidHALLMARK®
Myeloid Molecular Profile
NeoLAB® Solid Tumor Liquid Biopsy
Northstar Select™
OncoGuide™ NCC Oncopanel System
Oncomine Precision Assay
Oncomine™ Colon cfDNA Assay
OptiSeq™ Colorectal Cancer Panel
OptiSeq™ Lung Cancer Panel
OptiSeq™ Pan-Cancer Gene Panel
PancraGEN®
SOPHiA DDM™ Solid Tumor Plus Solution
SureSeq™ Pan-Myeloid Panel
Tempus xF Assay
ThyGeNEXT® + ThyraMIR®
TruSight Myeloid Sequencing Panel
TruSight Tumor 170 Assay
VarMap™ Pan-Cancer NGS Panel
oncoReveal™ Core LBx
oncoReveal™ Essential LBx
oncoReveal™ Multi-Cancer with CNV & RNA Fusion Panel
oncoReveal™ Solid Tumor v2 Panel
›
Associations
(4)
News
Trials
VERI cancer hierarchy
Reset Filters
GNAS mutation
Triple Negative Breast Cancer
GNAS mutation
Triple Negative Breast Cancer
Immunotherapy
Resistant: C3 – Early Trials
Immunotherapy
Resistant
:
C3
Immunotherapy
Resistant: C3 – Early Trials
Immunotherapy
Resistant
:
C3
GNAS R201C
Non Small Cell Lung Cancer
GNAS R201C
Non Small Cell Lung Cancer
trametinib + dabrafenib
Sensitive: C4 – Case Studies
trametinib + dabrafenib
Sensitive
:
C4
trametinib + dabrafenib
Sensitive: C4 – Case Studies
trametinib + dabrafenib
Sensitive
:
C4
ALK positive + ERCC3 E259D + GNAS A436_P459del
Non Small Cell Lung Cancer
ALK positive + ERCC3 E259D + GNAS A436_P459del
Non Small Cell Lung Cancer
lorlatinib
Resistant: C4 – Case Studies
lorlatinib
Resistant
:
C4
lorlatinib
Resistant: C4 – Case Studies
lorlatinib
Resistant
:
C4
GNAS amplification
Renal Cell Carcinoma
GNAS amplification
Renal Cell Carcinoma
cabozantinib capsule
Resistant: D – Preclinical
cabozantinib capsule
Resistant
:
D
cabozantinib capsule
Resistant: D – Preclinical
cabozantinib capsule
Resistant
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.